SinoTau

About:

SinoTau is a total solution provider specializing in generic drugs and innovative drugs.

Website: http://www.sinotau.com/

Top Investors: Qiming Venture Partners, SDIC Venture Capital, Xinshang Capital, Guangdong Technology Financial Group, Everest Venture Capital

Description:

SinoTau is a total solution provider specializing in generic drugs and innovative drugs. They provide cardiovascular fields, neurodegeneration fields, and tumor fields. The company specializes in the early development of antibody biopharmaceuticals and is researching a variety of medicines for use in treating cancers, neurological illnesses, and autoimmune diseases.

Total Funding Amount:

1.98B CNY

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2005-01-01

Contact Email:

sinotau(AT)sinotau.com

Founders:

Xinsheng Xu

Number of Employees:

101-250

Last Funding Date:

2023-07-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai